In Case You Missed It: “Perspectives on Vertical Payers” Is Out Now!

Article

In Case You Missed It: “Perspectives on Vertical Payers” Is Out Now!

October 13, 2022
Authors
Topics

Welcome to the October 2022 edition of our Monthly Insight Series. This month we discuss our new Perspectives on Vertical Payers report.

ipad reading

Greetings from San Mateo!

Time to check your inboxes! Just last week, we released Part 1 of our 2022 payer landscape reportPerspectives on Vertical Payers. It summarizes key drivers that lead the biggest payers to "go vertical,” describes vertical payer structures and the role of their healthcare services, and identifies their likely impact on manufacturers’ business landscape.

 This report reflects our commitment to help our valued clients…

  1. Enhance account team engagement with key payer customers
  2. Better understand potential contracting considerations
  3. Reconsider downstream field team interactions with certain provider accounts
  4. Support annual planning (strategic, accounts, business, etc.)

 

“Perspectives on Vertical Payers” Report Highlight

Payers are verticalizing to keep more revenues ‘in-house’ - our slide below features more insight on exactly why that is and how that affects the delivery of care: 

Converting costs to revenues: vertical payers keep more revenues in-house

Don’t hesitate to check out this report in our client portal and stay tuned next week for the release of Part 2, Vertical Payer Profiles, which delivers a deep dive into specifics about each of our country’s 6 largest vertical payers. 

As always, please reach out with any comments or questions you have.

All the best...
-- HMP Market Access Insights Team

The Latest

Easier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.
Article
Easier Pathway Access, Greater Pathway Usage

Easier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.

Cindy Chen
Our 2024-2025 Oncology Clinical Pathways Report, set for release in December, will provide insights into the most impactful pathways and key factors manufacturers should assess as the oncology pathways landscape continues to evolve.
Article
Unlocking Oncology Pathway Impact: Beyond Lives Covered to Real Prescribing Influence

As Oncology pathway programs continue to become more prominent in the marketplace, manufacturers are being challenged to assess how influential a specific pathway is.

Daniel Buchenberger
Podcast
Community Oncology Practice Economics - Podcast Part 3 of 3

In the final part of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore emerging models for success in oncology practice economics.

Lee Blansett